Generics - Financial

Filter

Current filters:

Financial

Popular Filters

51 to 75 of 2474 results

Robust 2013 for biotech licensing deals; average up-front payment jump 60%

28-03-2014

Biotech licensing deals have been trending up markedly in recent months, according to the new installment…

BiotechnologyFinancialLicensing

New HIV/AIDS drug will be offered through Brazil’s SUS

New HIV/AIDS drug will be offered through Brazil’s SUS

27-03-2014

A medicine that combines tenofovir (Gilead’s Viread) and lamivudine (GlaxoSmithKline’s Combivir)…

Anti-viralsBlanver FarmoquimicaBrazilGenericsLamivudineProductionSouth AmericaTenofovir Disoproxil Fumarate

Mylan prevails in breach of contract case against GlaxoSmithKline

Mylan prevails in breach of contract case against GlaxoSmithKline

27-03-2014

US generics major Mylan reveals that, after a trial in the US District Court for the District of New…

GenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalparoxetinePaxil-CR

Glenmark gets $4 million milestone in Forest collaboration

Glenmark gets $4 million milestone in Forest collaboration

27-03-2014

Indian drugmaker Glenmark Pharmaceuticals has informed the Stock Exchange today that the company through…

FinancialForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingPharmaceutical

US FDA approves NDA from Actavis and Valeant

US FDA approves NDA from Actavis and Valeant

26-03-2014

US generics major Actavis and Canada’s Valeant Pharmaceuticals said that the US Food and Drug Administration…

ActavisCanadaGenericsMetronidazolePharmaceuticalRegulationUSAValeant PharmaceuticalsWomen's Health

Solid financials from Stada but outlook sends stock down

Solid financials from Stada but outlook sends stock down

25-03-2014

German generic and branded drugmaker Stada Arzneimittel posted a solid set of financial results for 2013,…

FinancialGenericsSTADA Arzneimittel

GMiA welcomes the release of Australian Pharmaceutical Patent Review

25-03-2014

Members of the generic medicines industry sector in Australia say they welcome the release by IP Australia…

Asia-PacificAustraliaGenericsPatents

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal

24-03-2014

Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Lupin launches generic Niaspan in USA

24-03-2014

Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Actavis in Daytrana patent settlement

Actavis in Daytrana patent settlement

20-03-2014

Generic drugs major Actavis has entered into an agreement with Noven Pharmaceuticals, a subsidiary of…

ActavisDaytranaGenericsHisamitsu PharmaLegalNeurologicalNorth AmericaNoven PharmaceuticalsPatentsUSA

UK budget unveils £55 million Cell Therapy Manufacturing Centre

UK budget unveils £55 million Cell Therapy Manufacturing Centre

19-03-2014

The UK’s annual budget speech by Chancellor of the Exchequer George Osborne today included the announcement…

BiotechnologyFinancialPoliticsResearchUK

EGA calls for removal of barriers to competition and free trade for generics

EGA calls for removal of barriers to competition and free trade for generics

19-03-2014

The European Union must remove barriers to competition and free trade by introducing common sense reforms…

BiosimilarsEuropeGenericsMarkets & MarketingPatentsRegulation

Pfizer tackles Torrent over generic Viagra

Pfizer tackles Torrent over generic Viagra

19-03-2014

US pharma giant Pfizer is taking legal action against Indian drugmaker Torrent Pharmaceuticals to stop…

GenericsIndiaLegalMen's HealthPfizerPharmaceuticalTorrent PharmaceuticalsUSAViagra

ThromboGenics announces 2013 growth thanks to Jetrea sales

ThromboGenics announces 2013 growth thanks to Jetrea sales

18-03-2014

Belgium-based biopharma firm ThromboGenics has released its financial results for the full year 2013,…

BelgiumBiotechnologyFinancialJetreaOphthalmicsThromboGenics

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

17-03-2014

French biotech firm TxCell SA and privately-held Switzerland-headquartered Ferring International have…

BiotechnologyFerring PharmaceuticalsFinancialGastro-intestinalsLicensingOvaSaveTxCell

US Court upholds damages award in Actelion/Asahi litigation

14-03-2014

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalNorth AmericaRespiratory and PulmonaryUSA

Pharma Summit: AIDS activists picket to demand South African reform

Pharma Summit: AIDS activists picket to demand South African reform

14-03-2014

Delegates at The Economist’s Pharma Summit in London yesterday were greeted by AIDS activists picketing…

Anti-viralsFinancialLegalPharmaceuticalPricingSouth AfricaUK

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

14-03-2014

Even as India-based drug majors Ranbaxy and Wockhardt reel under the impact of US Food and Drug Administration…

Asia-PacificGenericsIndiaProductionRegulation

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

14-03-2014

Danish insulin giant Novo Nordisk revealed this morning that it is increasing its drug development capacity…

DiabetesFinancialNovo NordiskPharmaceuticalProduction

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada

13-03-2014

Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

13-03-2014

At the Annual Professional Pharmacy (APP) conference in Australia today, Mark Crotty, chairman of the…

Asia-PacificAustraliaGenericsHealthcarePolitics

51 to 75 of 2474 results

Back to top